Institutional investors purchased a net $3.2 million shares of ACHN during the quarter ended March 2016. This may signal that the smart money is gaining interest in this company as the 83.28% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FOX RUN MANAGEMENT LLC Bought 13.4 Thousand shares of Achillion Pharmaceuticals...
SIMPLEX TRADING LLC Bought 11.1 Thousand shares of Achillion Pharmaceuticals...